In a study using data from the American Society of Clinical Oncology Registry, researchers examined rates of COVID-19 vaccine uptake in patients with cancer who were positive for severe acute respiratory syndrome-coronavirus 2 (SARS–CoV-2). Their findings were published by Kurbegov et al in Cancer.
